Disposal
23 12월 2002 - 4:01PM
UK Regulatory
RNS Number:4838F
Whatman PLC
23 December 2002
Monday 23 December 2002
Whatman plc
Disposal of Whatman HemaSure
And Settlement of Litigation with Pall Corporation
Whatman plc ("Whatman") today announces that it has agreed to sell substantially
all of the assets of its Whatman HemaSure blood filtration business to Pall
Corporation for $5.95 million (#3.72 million) cash.
As part of the agreement, Whatman and Pall have also agreed to settle all their
outstanding litigation.
The agreement is subject only to the formal endorsement of the Colorado and New
York Courts, and completion of the transaction is expected during January.
The disposal of the Whatman HemaSure business will eliminate operating losses
which are expected to amount to approximately $5.5 million (#3.4 million) in
2002. The value of the net assets involved in the sale is $2.7 million (#1.7
million) and the transaction will result in a $12.8 million (#8.0 million)
write-off of goodwill net of acquisition provisions.
The proceeds of sale, net of exit costs will be applied to reduce Group debt.
Bob Thian, Chairman of Whatman, commented:
"The divestment of the HemaSure business will allow our management team to focus
its efforts on realising the full potential in Whatman's core businesses."
For further enquiries please contact:
Whatman plc Tel: 020 7581 0788
Bob Thian, Chairman
Financial Dynamics Tel: 0207 831 3113
David Yates / Ben Atwell
This information is provided by RNS
The company news service from the London Stock Exchange
END
DISEAKAAALKAFFE
Pall Corp (LSE:PLC)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Pall Corp (LSE:PLC)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Pall Corp (London Stock Exchange)의 실시간 뉴스: 최근 기사 0
More Pall Corporation News Articles